Enlivex to Present at the 4th Macrophage-Directed Therapies Summit

(marketscreener.com) Nes-Ziona, Israel, Oct. 03, 2022 -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced that company management will participate in, and present at, the 4th Macrophage-directed Therapies Summit, which is taking place in Boston, Massachusetts from October 4-6, 2022. Enlivex’s...https://www.marketscreener.com/quote/stock/ENLIVEX-THERAPEUTICS-LTD-56422776/news/Enlivex-to-Present-at-the-4th-Macrophage-Directed-Therapies-Summit-41914340/?utm_medium=RSS&utm_content=20221003